Idéal Investisseur
Français English
CAC 40 : Market open
8 079,05 pts
+0.01%


Last updated : 29/09/2026 - 15h00
🏠 Home   ➤    Stock news

Clariane stock rebounds 2% but remains below its three moving averages

The stock of the group specializing in nursing homes, clinics and home care services is gaining ground this Tuesday in a modestly advancing Paris market. The rebound occurs in a tense technical context, with the price remaining below its three moving averages despite today's momentum.


Clariane stock rebounds 2% but remains below its three moving averages

A rebound of nearly 2% that places Clariane among the best performers of the SBF 120

Clariane gains 1.96% during the session and is trading at €3.84, while the SBF 120 advances 0.33% and the CAC 40 rises 0.30%. This movement places the stock among the strongest gainers in the broader index. The advance echoes the rebound of September 21, when the stock defended its support at €3.80 with a surge of 3.5%.

The current price stands just above this level at €3.77, giving it the role of an immediate floor. The sector comparison with Emeis, whose stock gains 0.73% during the session, shows that Clariane significantly outperforms its peers today in the personal services sector.

A strengthened financial context but moving averages still weighing on momentum

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

The price remains below the 20-day MA at €3.95, the 50-day MA at €3.98 and the 200-day MA at €3.94, with respective gaps of 2.78%, 3.52% and 2.54%. This triple alignment below the moving averages reflects an underlying momentum still oriented downward, despite today's rebound. The RSI at 39 remains in the low zone without signaling clear oversold conditions, which leaves the configuration open. Over one month, the stock is down 1.39% and over three months down 9.22%, illustrating persistent pressure on the security.

On the fundamental side, the financial situation has nevertheless become clearer this autumn: a revolving credit line of 700 million euros maturing in 2031 was signed on September 22, shortly after a senior bond offering of 500 million euros completed in early September. When publishing H1 2026 results on July 29, the group targeted an improvement in its EBITDA margin of 100 to 150 basis points by end of 2026. The nearest resistance remains at €4.06, representing a gap of 5.7% from the current price.



Sector Services et infrastructure de santé › Etablissements de santé / EHPAD


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 2 699 millions d'euros
  • Quarterly revenue: 2 699 millions d'euros
  • Revenue growth: 1,6 %
  • EBITDA: 524 millions d'euros
  • EBITDA margin: 10,4 %
  • Net income: -47,5 millions d'euros
  • Free cash flow: 20 millions d'euros
  • 3 020 millions d'euros
Guidance from the release
  • Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
  • Environnement géopolitique complexe affectant les opérations de refinancement
  • Exposition aux épisodes climatiques frappant durement certains territoires en Europe
  • Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
  • Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
  • Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
  • Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
  • Expected revenue: 5 522 millions d'euros

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours